Navy beans may improve gut health and metabolism in colorectal cancer survivors

Incorporating navy beans into the diet of colorectal cancer (CRC) survivors has the potential to positively impact both gut and host health by modulating markers linked to obesity and disease, according to new research from The University of Texas MD Anderson Cancer Center.

MHRA extends the license of two cystic fibrosis drugs for children aged two to five years old

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (15 November 2023) extended the licence of the cystic fibrosis medicines Kaftrio (ivacaftor, tezacaftor and

November 20, 2023

J&J licenses LegoChem’s Trop2 ADC for $100M upfront

Johnson and Johnson’s subsidiary Janssen is licensing a Trop2 directed antibody-drug conjugate from South Korea’s LegoChem Biosciences in a deal that could be worth as

December 27, 2023

Risk adjusted net present value: What is the current valuation of TScan Therapeutics’s TSC-200-A0201?

TSC-200-A0201 is a gene-modified cell therapy commercialized by TScan Therapeutics, with a leading Phase I program in Metastatic Ovarian Cancer.

November 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.